Skip to main content
. 2013 May 28;8(5):e64490. doi: 10.1371/journal.pone.0064490

Figure 1. Ex vivo samples demonstrating proof of concept that AFM is able to visualise label-free drug-encapsulated NPs in tissues (a) CsA-NPs, (b) blood, (c) blood+NPs, (d) plasma, (e) plasma+NPs, (f) serum (g), serum+NPs, (h) kidney and (i) kidney+NPs.

Figure 1

(representative nanoparticles are marked by yellow arrows).